• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TyG和TyG-BMI指数对中国高海拔地区非酒精性脂肪性肝病的预测价值:一项横断面研究

Predictive Value of TyG and TyG-BMI Indices for Non-Alcoholic Fatty Liver Disease in High-Altitude Regions of China: A Cross-Sectional Study.

作者信息

Wang Xuejie, Wang Ziqiu, Du Wen, Ma Xiaobo, Ma Jun, Chen Zijin, Gao Chenni, Chen Xiaonong

机构信息

Department of Nephrology, Ruijin Hospital Lu Wan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

出版信息

J Clin Med. 2024 Dec 5;13(23):7423. doi: 10.3390/jcm13237423.

DOI:10.3390/jcm13237423
PMID:39685881
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11641996/
Abstract

The associations between triglyceride glucose (TyG), triglyceride glucose-body mass index (TyG-BMI), and non-alcoholic fatty liver disease (NAFLD) in high-altitude regions remain unclear. This is a cross-sectional, population-based study comprising 1384 adults living in Jianchuan county, China, which has an average altitude of over 2200 m. Logistic regressions were used to examine the associations between TyG, TyG-BMI, and NAFLD. Receiver operating characteristic (ROC) curves were utilized to compare the predictive ability of TyG, TyG-BMI, hepatic steatosis index (HSI), and triglyceride glucose-alanine aminotransferase (TyG-ALT). In total, 307 (35.7%) male and 81 (15.4%) female participants were diagnosed with NAFLD. Individuals with NAFLD had higher BMI, blood pressure, and TyG indices. The adjusted odds ratios (95% confidence intervals) for the highest quartile of TyG and TyG-BMI were 16.04 (8.51-30.25) and 48.55 (25.12-93.81), respectively. The areas under the ROC curve were 0.811 (95% CI: 0.787-0.836) for TyG, 0.883 (95% CI: 0.864-0.902) for TyG-BMI, 0.839 (95% CI: 0.817-0.863) for HSI, and 0.831 (95% CI: 0.801-0.855) for TyG-ALT. Tyg-BMI had the highest sensitivity (0.832) and specificity (0.780) compared to the other indices. Both TyG and TyG-BMI were associated with higher NAFLD risk in people living in high-altitude regions, while TyG-BMI had greater predictive capabilities.

摘要

在高海拔地区,甘油三酯葡萄糖(TyG)、甘油三酯葡萄糖-体重指数(TyG-BMI)与非酒精性脂肪性肝病(NAFLD)之间的关联仍不明确。这是一项基于人群的横断面研究,研究对象为居住在中国剑川县的1384名成年人,该县平均海拔超过2200米。采用逻辑回归分析来研究TyG、TyG-BMI与NAFLD之间的关联。利用受试者工作特征(ROC)曲线比较TyG、TyG-BMI、肝脏脂肪变性指数(HSI)和甘油三酯葡萄糖-丙氨酸氨基转移酶(TyG-ALT)的预测能力。共有307名(35.7%)男性和81名(15.4%)女性参与者被诊断为NAFLD。患有NAFLD的个体具有更高的体重指数、血压和TyG指数。TyG和TyG-BMI最高四分位数的校正比值比(95%置信区间)分别为16.04(8.51-30.25)和48.55(25.12-93.81)。TyG的ROC曲线下面积为0.811(95%CI:0.787-0.836),TyG-BMI为0.883(95%CI:0.864-0.902),HSI为0.839(95%CI:0.817-0.863),TyG-ALT为0.831(95%CI:0.801-0.855)。与其他指标相比,TyG-BMI具有最高的敏感性(0.832)和特异性(0.780)。TyG和TyG-BMI均与高海拔地区人群患NAFLD的较高风险相关,而TyG-BMI具有更强的预测能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b646/11641996/4fd6935a1d22/jcm-13-07423-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b646/11641996/4fd6935a1d22/jcm-13-07423-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b646/11641996/4fd6935a1d22/jcm-13-07423-g001.jpg

相似文献

1
Predictive Value of TyG and TyG-BMI Indices for Non-Alcoholic Fatty Liver Disease in High-Altitude Regions of China: A Cross-Sectional Study.TyG和TyG-BMI指数对中国高海拔地区非酒精性脂肪性肝病的预测价值:一项横断面研究
J Clin Med. 2024 Dec 5;13(23):7423. doi: 10.3390/jcm13237423.
2
Association between triglyceride glucose-body mass index and non-alcoholic fatty liver disease in the non-obese Chinese population with normal blood lipid levels: a secondary analysis based on a prospective cohort study.非肥胖血脂正常人群中甘油三酯-葡萄糖-体重指数与非酒精性脂肪肝的相关性:基于前瞻性队列研究的二次分析。
Lipids Health Dis. 2020 Oct 28;19(1):229. doi: 10.1186/s12944-020-01409-1.
3
The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.肥胖和脂质相关指标对预测非酒精性脂肪性肝病的存在的有用性。
Lipids Health Dis. 2021 Oct 10;20(1):134. doi: 10.1186/s12944-021-01561-2.
4
Triglyceride Glucose Index and Related Parameters (Triglyceride Glucose-Body Mass Index and Triglyceride Glucose-Waist Circumference) Identify Nonalcoholic Fatty Liver and Liver Fibrosis in Individuals with Overweight/Obesity.甘油三酯葡萄糖指数及相关参数(甘油三酯葡萄糖-体重指数和甘油三酯葡萄糖-腰围)可识别超重/肥胖个体的非酒精性脂肪肝和肝纤维化。
Metab Syndr Relat Disord. 2021 Apr;19(3):167-173. doi: 10.1089/met.2020.0109. Epub 2020 Dec 1.
5
The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population.甘油三酯-血糖-体重指数:一种在普通日本人群中识别非酒精性脂肪肝的非侵入性指标。
J Transl Med. 2022 Sep 5;20(1):398. doi: 10.1186/s12967-022-03611-4.
6
Fatty liver biomarkers and insulin resistance indices in the prediction of non-alcoholic fatty liver disease in Ghanaian patients.加纳患者中脂肪肝生物标志物和胰岛素抵抗指数对非酒精性脂肪肝的预测价值。
Endocrinol Diabetes Metab. 2023 Nov;6(6):e456. doi: 10.1002/edm2.456. Epub 2023 Oct 9.
7
Value of triglyceride glucose-body mass index in predicting nonalcoholic fatty liver disease in individuals with type 2 diabetes mellitus.甘油三酯血糖-体质指数在预测2型糖尿病患者非酒精性脂肪性肝病中的价值。
Front Endocrinol (Lausanne). 2025 Jan 20;15:1425024. doi: 10.3389/fendo.2024.1425024. eCollection 2024.
8
The potential of insulin resistance indices to predict non-alcoholic fatty liver disease in patients with type 2 diabetes.胰岛素抵抗指数预测2型糖尿病患者非酒精性脂肪性肝病的潜力。
BMC Endocr Disord. 2024 Dec 4;24(1):261. doi: 10.1186/s12902-024-01794-z.
9
Association between triglyceride glucose-body mass index and the staging of non-alcoholic steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease.甘油三酯-葡萄糖-体重指数与非酒精性脂肪性肝病患者非酒精性肝炎和纤维化分期的关系。
Ann Med. 2024 Dec;56(1):2409342. doi: 10.1080/07853890.2024.2409342. Epub 2024 Sep 30.
10
The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.甘油三酯与葡萄糖指数(TyG)是识别非酒精性脂肪性肝病的有效生物标志物。
Lipids Health Dis. 2017 Jan 19;16(1):15. doi: 10.1186/s12944-017-0409-6.

引用本文的文献

1
Association of triglyceride glucose-body mass index (TyG-BMI) with metabolic dysfunction-associated steatotic liver disease: A systematic review and meta-analysis.甘油三酯葡萄糖-体质指数(TyG-BMI)与代谢功能障碍相关脂肪性肝病的关联:一项系统评价和荟萃分析
PLoS One. 2025 Aug 4;20(8):e0324483. doi: 10.1371/journal.pone.0324483. eCollection 2025.

本文引用的文献

1
Association of triglyceride glucose-related parameters with all-cause mortality and cardiovascular disease in NAFLD patients: NHANES 1999-2018.NAFLD 患者甘油三酯-葡萄糖相关参数与全因死亡率和心血管疾病的关系:NHANES 1999-2018。
Cardiovasc Diabetol. 2024 Jul 18;23(1):262. doi: 10.1186/s12933-024-02354-4.
2
Assessment of the clinical value of five noninvasive predictors of metabolic dysfunction-associated steatotic liver disease in Han Chinese adults.评估五种非侵入性预测因子在汉族成年人代谢相关脂肪性肝病中的临床价值。
Eur J Gastroenterol Hepatol. 2024 Oct 1;36(10):1209-1219. doi: 10.1097/MEG.0000000000002806. Epub 2024 Jun 26.
3
Diagnostic performance of sixteen biomarkers for MASLD: A study in a Mexican cohort.
十六种 MASLD 诊断生物标志物的诊断性能:墨西哥队列研究。
Clin Res Hepatol Gastroenterol. 2024 Aug;48(7):102400. doi: 10.1016/j.clinre.2024.102400. Epub 2024 Jun 18.
4
Application value of triglyceride-glucose index and triglyceride-glucose body mass index in evaluating the degree of hepatic steatosis in non-alcoholic fatty liver disease.甘油三酯-葡萄糖指数和甘油三酯-葡萄糖体重指数在评估非酒精性脂肪性肝病肝脂肪变性程度中的应用价值。
Lipids Health Dis. 2023 Nov 3;22(1):186. doi: 10.1186/s12944-023-01954-5.
5
The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001-2018.甘油三酯-葡萄糖指数是糖尿病或糖尿病前期心血管疾病患者心血管和全因死亡的预测指标:来自 NHANES 2001-2018 的证据。
Cardiovasc Diabetol. 2023 Oct 17;22(1):279. doi: 10.1186/s12933-023-02030-z.
6
Cardiovascular physiology and pathophysiology at high altitude.高海拔地区的心血管生理学与病理生理学
Nat Rev Cardiol. 2024 Feb;21(2):75-88. doi: 10.1038/s41569-023-00924-9. Epub 2023 Oct 2.
7
Diagnostic value of triglyceride-glucose index and related parameters in metabolism-associated fatty liver disease in a Chinese population: a cross-sectional study.中国人代谢相关脂肪性肝病中甘油三酯-葡萄糖指数及相关参数的诊断价值:一项横断面研究。
BMJ Open. 2023 Sep 29;13(9):e075413. doi: 10.1136/bmjopen-2023-075413.
8
Liver Fat Scores for Noninvasive Diagnosis and Monitoring of Nonalcoholic Fatty Liver Disease in Epidemiological and Clinical Studies.用于非酒精性脂肪性肝病流行病学和临床研究中无创诊断及监测的肝脏脂肪评分
J Clin Transl Hepatol. 2023 Oct 28;11(5):1212-1227. doi: 10.14218/JCTH.2022.00019. Epub 2023 May 31.
9
A multisociety Delphi consensus statement on new fatty liver disease nomenclature.多学会专家共识:新的非酒精性脂肪性肝病命名。
Hepatology. 2023 Dec 1;78(6):1966-1986. doi: 10.1097/HEP.0000000000000520. Epub 2023 Jun 24.
10
Emerging trends and hotspots in metabolic dysfunction-associated fatty liver disease (MAFLD) research from 2012 to 2021: A bibliometric analysis.2012 年至 2021 年代谢功能障碍相关脂肪性肝病(MAFLD)研究的新兴趋势和热点:文献计量分析。
Front Endocrinol (Lausanne). 2023 Jan 24;14:1078149. doi: 10.3389/fendo.2023.1078149. eCollection 2023.